Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial.
Authors: Sharma S; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio., Lin P; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio., Hu A; Cumberland Valley Retina PC, Hagerstown, Maryland., Suhler EB; Casey Eye Institute and VA Portland Health Care System, Portland, Oregon., Pauly-Evers M; Roche Pharma Research and Early Development, Basel, Switzerland., Holmes W; Roche Products Ltd, Welwyn Garden City, United Kingdom., Barekati Z; Roche Pharma Research and Early Development, Basel, Switzerland., Willen D; Roche Pharma Research and Early Development, Basel, Switzerland., Macgregor L; F. Hoffmann-La Roche AG, Basel, Switzerland., Steeples L; Roche Products Ltd, Welwyn Garden City, United Kingdom., Haskova Z; Genentech, Inc, South San Francisco, California., Feenstra D; Roche Pharma Research and Early Development, Basel, Switzerland., Silverman D; Roche Products Ltd, Welwyn Garden City, United Kingdom., Passemard B; Roche Pharma Research and Early Development, Basel, Switzerland., Fauser S; Roche Pharma Research and Early Development, Basel, Switzerland., Mesquida M; Roche Pharma Research and Early Development, Basel, Switzerland.; F. Hoffmann-La Roche AG, Basel, Switzerland.
Source: JAMA ophthalmology [JAMA Ophthalmol] 2026 May 01; Vol. 144 (5), pp. 442-451.
Publication Type: Journal Article; Multicenter Study; Clinical Trial, Phase I
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41954903
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sharma+S%22">Sharma S</searchLink>; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Lin+P%22">Lin P</searchLink>; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Hu+A%22">Hu A</searchLink>; Cumberland Valley Retina PC, Hagerstown, Maryland.<br /><searchLink fieldCode="AU" term="%22Suhler+EB%22">Suhler EB</searchLink>; Casey Eye Institute and VA Portland Health Care System, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Pauly-Evers+M%22">Pauly-Evers M</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Holmes+W%22">Holmes W</searchLink>; Roche Products Ltd, Welwyn Garden City, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barekati+Z%22">Barekati Z</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Willen+D%22">Willen D</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Macgregor+L%22">Macgregor L</searchLink>; F. Hoffmann-La Roche AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Steeples+L%22">Steeples L</searchLink>; Roche Products Ltd, Welwyn Garden City, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Haskova+Z%22">Haskova Z</searchLink>; Genentech, Inc, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Feenstra+D%22">Feenstra D</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Silverman+D%22">Silverman D</searchLink>; Roche Products Ltd, Welwyn Garden City, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Passemard+B%22">Passemard B</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fauser+S%22">Fauser S</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mesquida+M%22">Mesquida M</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.; F. Hoffmann-La Roche AG, Basel, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589539%22">JAMA ophthalmology</searchLink> [JAMA Ophthalmol] 2026 May 01; Vol. 144 (5), pp. 442-451.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589539 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6173 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686165%22">21686165 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Ophthalmol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41954903
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaophthalmol.2026.0610
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 442
    Titles:
      – TitleFull: Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sharma S
      – PersonEntity:
          Name:
            NameFull: Lin P
      – PersonEntity:
          Name:
            NameFull: Hu A
      – PersonEntity:
          Name:
            NameFull: Suhler EB
      – PersonEntity:
          Name:
            NameFull: Pauly-Evers M
      – PersonEntity:
          Name:
            NameFull: Holmes W
      – PersonEntity:
          Name:
            NameFull: Barekati Z
      – PersonEntity:
          Name:
            NameFull: Willen D
      – PersonEntity:
          Name:
            NameFull: Macgregor L
      – PersonEntity:
          Name:
            NameFull: Steeples L
      – PersonEntity:
          Name:
            NameFull: Haskova Z
      – PersonEntity:
          Name:
            NameFull: Feenstra D
      – PersonEntity:
          Name:
            NameFull: Silverman D
      – PersonEntity:
          Name:
            NameFull: Passemard B
      – PersonEntity:
          Name:
            NameFull: Fauser S
      – PersonEntity:
          Name:
            NameFull: Mesquida M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6173
          Numbering:
            – Type: volume
              Value: 144
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: JAMA ophthalmology
              Type: main
ResultId 1